Quantitative cell-based bioassays for therapeutic development targeting immune checkpoint and co-stimulatory receptors

被引：0
|
作者：
Grailer, Jamison
Stecha, Pete
Wang, Jun
Hartnett, Jim
Fan, Frank
Cong, Mei
Cheng, Zhi-jie Jey
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4878
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4878
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Immune Checkpoint and Immunostimulatory Reporter Bioassays to Advance the Development of Therapeutic Antibodies in Immunotherapy Research Programs
    Somberg, Richard
    Cong, Mei
    Cheng, Zhi-jie Jey
    Grailer, Jamison J.
    Stecha, Pete
    Wang, Jun
    Hartnett, Jim
    Fan, Frank
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [32] The role of the T-cell inducible co-stimulatory molecule ICOS in the development of atherosclerosis
    Gotsman, I
    Grabie, N
    DaCosta, R
    Lichtman, A
    FASEB JOURNAL, 2006, 20 (04): : A199 - A199
  • [33] Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
    Rapoport, Bernardo L.
    Steel, Helen C.
    Hlatshwayo, Nomsa
    Theron, Annette J.
    Meyer, Pieter W. A.
    Nayler, Simon
    Benn, Carol-Ann
    Smit, Teresa
    Kwofie, Luyanda L. I.
    Heyman, Liezl
    Anderson, Ronald
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
    Chester, Cariad
    Fritsch, Katherine
    Kohrt, Holbrook E.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [35] Development of cell-based sensor array for targeting multiple odorants based on insect odorant receptors
    Termtanasombat, Maneerat
    Mitsuno, Hidefumi
    Misawa, Nobuo
    Yamahira, Shinya
    Yamaguchi, Satoshi
    Nagamune, Teruyuki
    Kanzaki, Ryohei
    CHEMICAL SENSES, 2016, 41 (09) : E258 - E258
  • [36] Development of novel cell-based bioassays for the development of biologics targeting LAG-3 and PD-1xLAG-3
    Grailer, Jamison
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Drug immunogenicity and co-stimulatory signalling: evidence for formation of a functional antigen through immune cell metabolism
    Elsheikh, A.
    Lavergne, S.
    Castrejon, J.
    Sathish, J.
    Pichler, W. J.
    Park, B. K.
    Naisbitt, D. J.
    IMMUNOLOGY, 2010, 131 : 145 - 145
  • [38] Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy n stroke
    Bodhankar, Sheetal
    Chen, Yingxin
    Lapato, Andrew
    Vandenbark, Arthur A.
    Murphy, Stephaine J.
    Offner, Halina
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [39] Dual roles for regulatory T cell depletion and co-stimulatory signaling in agonistic GITR targeting for tumor immunotherapy
    Beebe, A.
    Mahne, A.
    Mauze, S.
    Joyce-Shaikh, B.
    Cua, D.
    Jain, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S100 - S100
  • [40] Identification of novel T cell co-inhibitory and co-stimulatory receptors from screening a comprehensive library of extracellular proteins
    Brace, Arthur
    Sallee, Nathan
    Chou, Justin
    Garrenton, Lindsay
    Chen, Diana
    Liang, Ryan
    Kemper, Greg
    Yang, David
    Jaquez, Marina
    Powers, Janine
    Mkrtichyan, Mikayel
    Brennan, Thomas
    Borges, Luis
    CANCER RESEARCH, 2017, 77
12345